***͡èҡѭաҧ***

-ѡࡳԡ¤ѡҾҺѺäԵԷҫ觨繵ͧҷդ٧(33)(19/01/2561)

-ѡࡱԡ¤ѡҾҺѺäԵԷҫ觨繵ͧҷդ٧(34)(19/01/2561)

-ѡࡱԡ¤ѡҾҺѺäԵԷҫ觨繵ͧҷդ٧()(424)(20/09/2561)

-ǷҧӡѺԡ¤¹AprepitantPalonosetron

-¡ѡäԵԷҷԡкԡµçѡҾҺż¹͡

  • ẺѺŧ¹ç
  • OCPA
  • RDPA
  • DDPA

Ẻŧ¹âԡҹ͡ѭѡ觪ҵ(OCPA)

Chronic myeloid leukemia (IMT-CML)

:Imatinib (Glivec)

Chronic myeloid leukemia (NLT-CML)

:Niotinib (Tasigna)

Chronic myeloid leukemia (DST-CML)

:Dasatinib (Sprycel)

Diffuse large Bcell lymphoma (RTX-DLBCL)

:Rituximab (Mebthera)

Follicular Lymphoma (RTX-FCL)

:Rituximab (Mebthera)

Marginal zone Lymphoma (RTX-MZL)

:Rituximab (Mebthera)

Mantle cell Lymphoma (RTX-MCL)

:Rituximab (Mebthera)

Chronic lymphocytic leukemia/SLL (RTX-CLL)

:Rituximab (Mebthera)

Gastrointestinal Stromal tumor (IMT-GIST)

:Imatinib (Glivec)

Gastrointestinal Stromal tumor (SNT-GIST)

:Sunitinib (Sutent)

Early breast cancer (TTZ-EBC)

:Trastuzumab (Herceptin)

Metastatic breast cancer (TTZ-MBC)

:Trastuzumab (Herceptin)

Multiple myeloma (BTZ-MM)

:Bortezomib (Velcade)

Non-small cell lung cancer (GFT-NSL)

:Gefitinib (Iressa)

Acute Lymphoblastic Leukemia Դ Philadelphia chromosome positive (ALL Ph+)(IMT-ALL)

:Imatinib (Glivec)

Acute Lymphoblastic Leukemia Դ Philadelphia chromosome positive (ALL Ph+)(DST-ALL)

:Dasatinib (Sprycel)

Renal cell carcinoma (PZP-RCC)

:Pazopanib ( Votrient)

Metastatic or Inoperable Non-lipogenic Soft Tissue Sarcoma (PZP-STS)

:Pazopanib (Votrient)

Metastatic prostate cancer (EZM-CRPC)

:Enzalutamide (Xtandi)

Metastatic colorectal cancer RAS-WT (PNM-CRC)

:Panitumumab (Vectibix)

Non-small cell lung cancer, ALK+ (CRT-NSL)

:Ceritinib (Zykadia)

High-risk advanced ovarian cancer (stage IIIB-IV) (BCZ-OVC)

:Bevacizumab (Avastin)

Metastatic prostate cancer (ABT-CRPC)

:Abiraterone (Zytiga)

 

Ẻŧ¹âԡҹ͡ѭѡ觪ҵ (RDPA)
Ankylosing Spondylytis (AS-ETA)
Ankylosing Spondylytis (AS-INF)
Rheumatoid arthritis (RA-ETA)
Rheumatoid arthritis (RA-INF)
Rheumatoid arthritis (RA-RTX)
Juvenile ldiopathic arthritis (JIA-ETA)
Juvenile ldiopathic arthritis (JIA-INF)
Psoriasis Arthritis (PsA-ETA)
Psoriasis Arthritis (PsA-INF)

 

Ẻŧ¹âԡҹ͡ѭѡ觪ҵ (DDPA)
Moderate to severe Psoriasis (PS-INF)
Moderate to severe Psoriasis (PS-ETA)